Haemonetics Corporation (HAE)

Debt-to-equity ratio

Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 820,836 959,959 817,997 749,424 731,670
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00

March 31, 2025 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $820,836K
= 0.00

The debt-to-equity ratio for Haemonetics Corporation has been consistently reported as 0.00 from March 31, 2021, to March 31, 2024. However, the data for March 31, 2025, is denoted as "—". A debt-to-equity ratio of 0.00 generally indicates that the company has no debt or a negligible amount of debt in relation to its equity. This suggests that the company relies more on equity financing rather than debt financing, which can be seen as a positive sign, as it implies lower financial risk and a strong financial position. The missing data for March 31, 2025, warrants further investigation to evaluate any potential changes in the company's capital structure.